Area of research
Pulmonary and Respiratory Medicine · Radiation
Research interest
Research interests include Prostate Cancer Diagnosis and Treatment, Prostate Cancer Treatment and Research, Advanced Radiotherapy Techniques, and Immunotherapy and Immune Responses.
NKX2-1 drives neuroendocrine transdifferentiation of prostate cancer via epigenetic and 3D chromatin remodeling
A simplified MyProstateScore2.0 for high-grade prostate cancer
Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer
Differentiation fate of a stem-like CD4 T cell controls immunity to cancer
Upgrading of Grade Group 1 Prostate Cancer at Prostatectomy: Germline Risk Factors in a Prospective Cohort
Integrated Genomic Analysis of Primary Prostate Tumor Foci and Corresponding Lymph Node Metastases Identifies Mutations and Pathways Associated with Metastasis
CD8+ T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor
High throughput, label-free isolation of circulating tumor cell clusters in meshed microwells
A panel of selected serum protein biomarkers for the detection of aggressive prostate cancer
Genetic factors associated with prostate cancer conversion from active surveillance to treatment
Cancer and Leukemia Group B 90203 (Alliance): Radical Prostatectomy With or Without Neoadjuvant Chemohormonal Therapy in Localized, High-Risk Prostate Cancer
An intra-tumoral niche maintains and differentiates stem-like CD8 T cells
A four‐group urine risk classifier for predicting outcomes in patients with prostate cancer
Circulating microRNAs in plasma among men with low‐grade and high‐grade prostate cancer at prostate biopsy
Patient-reported outcomes after treatment for clinically localized prostate cancer: A systematic review and meta-analysis
Circulating microRNAs in plasma as potential biomarkers for the early detection of prostate cancer
Adoption of Prebiopsy Magnetic Resonance Imaging for Men Undergoing Prostate Biopsy in the United States
Incorporation of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG into Prostate Cancer Prevention Trial Risk Calculator
Evaluating Clinical Implementation Approaches for Prostate Cancer Decision Support
Association Between Combined <i>TMPRSS2:ERG</i> and <i>PCA3</i> RNA Urinary Testing and Detection of Aggressive Prostate Cancer
Gleason Score 7 Prostate Cancers Emerge through Branched Evolution of Clonal Gleason Pattern 3 and 4
Decision Support with the Personal Patient Profile-Prostate: A Multicenter Randomized Trial
External Beam Radiation Therapy or Brachytherapy With or Without Short-course Neoadjuvant Androgen Deprivation Therapy: Results of a Multicenter, Prospective Study of Quality of Life
Detection of prostate cancer‐specific transcripts in extracellular vesicles isolated from post‐DRE urine
Prostate Health Index improves multivariable risk prediction of aggressive prostate cancer
Initial Report of NRG Oncology/RTOG 0232: A Phase 3 Study Comparing Combined External Beam Radiation and Transperineal Interstitial Permanent Brachytherapy With Brachytherapy Alone for Selected Patients With Intermediate-Risk Prostatic Carcinoma
Clinical Use of Expanded Prostate Cancer Index Composite for Clinical Practice to Assess Patient Reported Prostate Cancer Quality of Life Following Robot-Assisted Radical Prostatectomy
Relief of Urinary Symptom Burden after Primary Prostate Cancer Treatment
Multicenter Evaluation of the Prostate Health Index to Detect Aggressive Prostate Cancer in Biopsy Naïve Men
Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS Cohort